Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Combined HDAC and ATM inhibition with radiation in preclinical glioblastoma models

Background: Brain-penetrant histone deacetylase inhibitors (HDACi) are promising radiosensitizing agents for glioblastoma (GBM). HDAC inhibitors can impair DNA damage response (DDR) pathways and promote persistent DNA damage. Here, we evaluated whether combined inhibition of HDAC and the DNA repair kinase, ataxia-telangiectasia mutated (ATM), could synergize with radiation (IR) and improve…

In preclinical glioblastoma models, combining HDAC and ATM inhibition with radiation showed promise in enhancing therapeutic efficacy. The study examined the effects of quisinostat (QST) and ataxia-telangiectasia mutated (ATM) kinase inhibition in combination with radiation on glioma stem cells derived from patient-derived xenografts (PDX).

The results revealed a synergistic radiosensitization effect when QST and ATM were inhibited together with radiation treatment in vitro. Immunoblotting analyses indicated increased histone acetylation and suppressed DDR signaling after QST and IR treatment, suggesting that QST accelerated DNA damage and disrupted DDR mechanisms in a non-direct manner.

Transcriptomic analysis further confirmed changes in DNA repair pathways. While the combination of QST and IR significantly improved survival in an orthotopic GBM model, adding ATM inhibition (AZD1390) did not yield a significant survival benefit beyond QST+IR treatment. The study concluded that the in vitro synergy did not translate into additional survival benefit in an orthotopic GBM model, indicating potential pharmacological limitations related to the tumor microenvironment or suboptimal dosing schedules.

Written by urgent.news from bioRxiv's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at biorxiv.org →

More in Health & Medicine

More from Wednesday 7 October →